首页|期刊导航|中成药|UPLC-Q-TOF-MS/MS法鉴定3种酚类在小鼠体内的代谢产物

UPLC-Q-TOF-MS/MS法鉴定3种酚类在小鼠体内的代谢产物OA

Identification of in vivo metabolites of three phenols in mice by UPLC-Q-TOF-MS/MS

中文摘要英文摘要

目的 建立UPLC-Q-TOF-MS/MS法鉴定没食子酸、鞣花酸、柯里拉京在小鼠体内的代谢产物.方法 给药组小鼠分别灌胃给予 3 种成分的 0.5%CMC-Na混悬液(400 mg/kg),空白组小鼠灌胃给予 0.5%CMC-Na混悬液(400 mg/kg),采集血浆、尿液、粪便.分析采用Acquity UPLC HSS T3 色谱柱(100 mm×2.1 mm,1.8 μm);流动相水(含 0.1%甲酸)-乙腈,梯度洗脱;体积流量 0.27 mL/min;柱温 30℃;电喷雾离子源;负离子扫描.结果 共鉴定出27 种没食子酸代谢产物、13 种鞣花酸代谢产物、37 种柯里拉京代谢产物,这 3 种成分主要发生水解、脱羧等Ⅰ相代谢,以及甲基化、硫酸化、葡萄糖醛酸化等Ⅱ相代谢.结论 该方法稳定可靠,可为探究其他天然酚类的体内代谢规律提供参考.

AIM To establish a UPLC-Q-TOF-MS/MS method for the identification of in vivo metabolites of gallic acid,ellagic acid and corilagin in mice.METHODS The mice in administration groups were given intragastric administration of 0.5%CMC-Na suspensions of 3 constituents(400 mg/kg),respectively,while those in blank group were given intragastric administration of 0.5%CMC-Na suspensions(400 mg/kg),after which plasma,urine and feces were collected.The analysis was performed on a 30℃thermostatic Acquity UPLC HSS T3 column(100 mm×2.1 mm,1.8 μm),with the mobile phase comprising of water(containing 0.1%formic acid)-acetonitrile flowing at 0.27 mL/min in a gradient elution manner,and electrospray ionization source was adopted in negative ion scanning.RESULTS Total 27 gallic acid metabolites,13 ellagic acid metabolites and 37 corilagin metabolites were identified,these 3 constituents mainly occured phase Ⅰmetabolites such as hydrolysis,decarboxylation,and phase Ⅱ metabolites such as methylation,sulfation,glucuronidation.CONCLUSION This stable and reliabe method can provide a reference for exploring the in vivo metabolic rules of other natural phenols.

赵蓉;胡蒙蒙;洪玉冰;雷胜男;赵子康;车彦云

云南中医药大学,云南省药食同源饮品工程研究中心,云南 昆明 650500云南中医药大学,云南省药食同源饮品工程研究中心,云南 昆明 650500云南中医药大学,云南省药食同源饮品工程研究中心,云南 昆明 650500云南中医药大学,云南省药食同源饮品工程研究中心,云南 昆明 650500云南中医药大学,云南省药食同源饮品工程研究中心,云南 昆明 650500云南中医药大学,云南省药食同源饮品工程研究中心,云南 昆明 650500

医药卫生

没食子酸鞣花酸柯里拉京代谢产物UPLC-Q-TOF-MS/MS

gallic acidellagic acidcorilaginmetabolitesUPLC-Q-TOF-MS/MS

《中成药》 2026 (1)

33-41,9

兴滇英才支持计划项目(20220273)云南省基础研究计划项目面上项目(202401AT070160)云南省科技厅-云南中医药大学应用基础联合研究专项项目面上项目(202101AZ070001-212)云南省科技厅-云南中医药大学应用基础联合研究专项项目重点项目(2019FF002-012)

10.3969/j.issn.1001-1528.2026.01.006

评论